Clinical Trials Directory

Trials / Completed

CompletedNCT03289559

Effects of Testosterone and Fat Utilization

Testosterone Effects on Systemic Lipolysis and Whole Body Lipid Utilization

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
13 (actual)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
25 Years – 45 Years
Healthy volunteers
Accepted

Summary

Evidence is accumulating that there are sex differences in energy and substrate metabolism. The positive or negative consequences of such metabolic differences between men and women need to be evaluated with respect to health outcomes. The importance of aberrant lipid metabolism in metabolic diseases such as obesity, diabetes and cardiovascular disease, makes understanding the distinction between "normal" vs aberrant critical to future treatment and prevention strategies. Sex differences in the effects of catecholamines on lipid metabolism and substrate oxidation in non-obese, healthy individuals, have been consistently observed. In addition, distinct differences in men and women exist in the distribution of body fat, with men typically having greater central adiposity than women. Accumulation of fat in the abdomen is associated with an increased risk for metabolic abnormalities such as hyperlipidemia and insulin resistance. In the current study, therefore, the role of testosterone in determining the sex differences in catecholamine mediated substrate metabolism and deposition of dietary fat into upper versus lower body adipose tissue depots will be addressed.

Conditions

Interventions

TypeNameDescription
DRUGGnRH antagonist
DRUGAromatase Inhibitors
DRUGTestosterone gel

Timeline

Start date
2006-01-01
Primary completion
2011-01-01
Completion
2014-01-01
First posted
2017-09-21
Last updated
2017-09-21

Source: ClinicalTrials.gov record NCT03289559. Inclusion in this directory is not an endorsement.